ArticleEuropean heart journal. Imaging methods and practice2026
Hyperaemic effects of adenosine and dobutamine in heart failure with reduced ejection fraction: a quantitative perfusion CMR study.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03661827 (Diagnostic Accuracy in Left Ventricular Systolic Dysfunction for Identifying Coronary Artery Disease With Dobutamine Versus Adenosine Non-invasive Stress Cardiac Magnetic Resonance Evaluation), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Diagnostic Accuracy in Left Ventricular Systolic Dysfunction for Identifying Coronary Artery Disease With Dobutamine Versus Adenosine Non-invasive Stress Cardiac Magnetic Resonance Evaluation
Who cites it
1 citing paper in PubMed.
- Beta-blocker exposure and dobutamine hyperaemia in heart failure with reduced ejection fraction.European heart journal. Imaging methods and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: In patients with heart failure with reduced ejection fraction (HFrEF), determining the aetiology of cardiac dysfunction has important therapeutic and prognostic implications. Cardiovascular magnetic resonance (CMR) enables comprehensive phenotyping of HFrEF; however, it remains uncertain whether the choice of pharmacological stress agent influences the hyperaemic response required for reliable ischaemia assessment. We sought to compare the hyperaemic effects of adenosine and dobutamine in patients with HFrEF using quantitative perfusion CMR. Methods and results: Patients with HFrEF [left ventricular ejection fraction (LVEF) ≤40%] prospectively underwent 3-Tesla CMR comprising functional cine imaging, late gadolinium enhancement (LGE), and first-pass perfusion imaging at rest and during pharmacological stress with (i) adenosine (140-210 μg/kg/min) and (ii) dobutamine (10-30 µg/kg/min). Perfusion maps were reconstructed inline with automated, pixel-wise quantification of myocardial blood flow (MBF). The hyperaemic response, defined by global myocardial perfusion reserve (MPR), was calculated as the quotient of stress and rest MBF and compared between stress protocols. Fifty-three patients with HFrEF (mean age 63 ± 10 years, 77% male, mean LVEF 36 ± 10%, infarction 59%, and non-ischaemic focal fibrosis 21%) with paired adenosine and dobutamine stress-perfusion data were analysed. Compared with dobutamine, adenosine produced a higher global MPR [mean difference: +0.61 (95% CI: 0.35, 0.88); Conclusion: In patients with HFrEF, adenosine induces a greater hyperaemic response than dobutamine; however, whether this impacts on the diagnostic assessment of ischaemia remains to be established (Trial registration: NCT03661827).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.